Journal
Stories, science, and straight talk
Evidence-based writing on perimenopause, menopause, and midlife wellness. From our care team to you.
Symptoms & treatment
Peptide News This Week: The FDA's Big BPC-157 Vote, a 22.6% Weight-Loss Result, and What It All Means for Your Midlife Health
An FDA panel voted to allow BPC-157 back in compounding pharmacies, and retatrutide hit 22.6% weight loss. Here is what this week's peptide news means for your midlife health.
Hormone therapy
New ENDO 2026 Research: Hormone Therapy May Protect Your Bones, Brain, and Mood, Not Just Treat Hot Flashes
ENDO 2026 research links menopausal hormone therapy to a 69% lower risk of low bone density, plus cognitive and mood findings. What it means for your care.
Hormone therapy
How Long Does It Take to Feel Results on HRT? A Realistic Timeline for Women
A realistic, symptom-by-symptom timeline for HRT in perimenopause and menopause: what to expect from hot flashes, sleep, mood, vaginal symptoms, and more.
Symptoms & treatment
Everyone Is Talking About Peptides. But Which Ones Are Actually FDA Approved?
What peptides are, which peptide-based medications are actually FDA approved, what the FDA's 2026 compounding review means, and how to evaluate peptide therapy.
Bone, heart & long-term health
Perimenopause and Insulin Resistance: The Hidden Reason Many Women Gain Weight After 40
Why insulin resistance accelerates during perimenopause, what SWAN research shows about midlife body composition changes, and how to support metabolic health.
Symptoms & treatment
GLP-1 Medications: A Comprehensive Guide to Weight Loss, Diabetes Management, and What to Know Before Starting
A complete guide to GLP-1 medications: how they work, FDA-approved options like Wegovy and Zepbound, who qualifies, risks, side effects, and what to expect.